as sales. Although the Company will has been better administration for cost of sales and control expenses than previous year, as a result to revenue recognition and gross profit was decrease. Net

from last year at 12.55% as the company implemented better production cost control for new products that could cause an improvement in production efficiency and could reduce loss in many as aspects. 3

year-ended 31 December 2019 was 197.9 million baht compared to 213.3 million baht the same period last year, decreased 15.4 million baht or 7.2 percent due to an ongoing cost control measures. Over the

December 31, 2019 was Baht 1,530.75, decreased by Baht 133.24 million or 8.01% from last year, driven by the Company was able to control the debt internally both the Company and its subsidiaries. 3

cost. 3) Selling and Administration Expenses Selling and administration expenses decreased by Baht 11.4 million, or 6.5% from Q2/2016, as a result of improved efficiency in cost and expenses control. 4

expenses control. Other Transaction In year 2017 there were Baht 6.2 million from loss on change in fair value less costs to sell of biological assets, Baht 26.3 million and Baht 16.2 million from new office

the area and the cost control methods had been improved. The company has the cost of sales in the amount 2.33 million baht, compared to the previous year 0.68 million baht, an increase of 1.65 million

with QoQ. This is due to the decrease in write off obsolete finished goods and better control. The Company reported shutdown expenses for inventory management against sales volume at Baht 15.7 million

the gross margin. Company able to control cost better than last year. With a gross margin of 25% in 2018 and 23% in 2017. 1.3 Other income is the indirect business income generated by the Company such

quarter of 2019, increase of 29 million baht or 15% from the same period of last year mainly came from increasing of revenue and greater control cost of project. Distribution costs In the third quarter of